Our Services
Medical Information
Helpful Resources
Published on: 3/1/2026
New skin bumps can be caused by neurofibromatosis, a genetic disorder where nerve tumors form; NF1 often causes soft skin neurofibromas and café au lait spots, while NF2 and schwannomatosis affect nerves differently, and most tumors are benign but need monitoring due to possible complications and a small cancer risk.
There are several factors to consider; see below for the key warning signs, how diagnosis and genetic testing are done, when to seek urgent vs routine care, and treatment and follow up choices, with critical details that could change your next steps.
Noticing new skin bumps can be unsettling. While many skin growths are harmless, in some cases they may be linked to a genetic condition called neurofibromatosis. Understanding what neurofibromatosis is, why it forms, and what to do next can help you move forward calmly and confidently.
This guide explains the causes, symptoms, diagnosis, and medical next steps — using clear, practical language based on credible medical sources.
Neurofibromatosis (NF) is a genetic disorder that causes tumors to form along nerves in the body. These tumors are usually benign (non-cancerous), but they can sometimes lead to complications depending on their size and location.
There are three main types:
Each type affects the body differently, but NF1 is most often associated with visible skin bumps.
Neurofibromatosis is caused by changes (mutations) in specific genes that normally help control cell growth.
If a parent has NF1 or NF2, there is a 50% chance of passing it to their child.
In NF1, the most recognizable feature is the development of neurofibromas — soft, flesh-colored or slightly purple bumps on or under the skin.
They may:
Other common skin findings in NF1 include:
In NF2, skin bumps are less common. Instead, symptoms often involve:
Most neurofibromas are benign and slow-growing. However, neurofibromatosis is not just a cosmetic condition.
Possible complications may include:
The lifetime risk of cancerous change in people with NF1 is estimated at about 8–13%, which means it is uncommon but important to monitor.
The key is ongoing medical supervision, not panic.
You should speak to a doctor if you notice:
Early evaluation allows doctors to determine whether the bumps are related to neurofibromatosis or something more common and harmless, like lipomas or skin tags.
If anything feels severe, rapidly worsening, or life-threatening, seek urgent medical care immediately.
Diagnosis is based on:
Doctors look for specific criteria, especially in NF1, such as:
Blood tests can identify gene mutations. This is especially helpful if symptoms are unclear.
MRI scans may be used to check for internal tumors, especially in NF2.
Important in suspected NF2.
If you're experiencing symptoms like unusual skin bumps or café-au-lait spots and want to understand whether they could be related to Neurofibromatosis, a free AI-powered symptom checker can help you organize your concerns before your medical appointment.
There is no cure for neurofibromatosis, but treatment focuses on managing symptoms and complications.
Treatment is highly individualized. Many people with neurofibromatosis live full, productive lives with careful medical follow-up.
The severity varies widely.
Some people have only mild skin findings and minimal complications. Others may experience more complex health challenges.
Important things to remember:
Emotional support can also be important. Visible skin bumps may affect self-confidence. Speaking with a counselor or joining a support group can be helpful.
If you've noticed new skin bumps and are wondering about neurofibromatosis:
If you experience severe pain, sudden neurological symptoms, hearing loss, or rapidly growing masses, seek urgent medical care.
New skin bumps deserve attention — not panic. With accurate information and medical guidance, you can take clear, confident next steps. If you have concerns about neurofibromatosis or any potentially serious symptoms, make an appointment with a qualified healthcare professional as soon as possible.
(References)
* Gutmann DH, Ferner RE, Evans DG, Korf BR. Neurofibromatosis type 1. Nat Rev Dis Primers. 2017 Jul 27;3:17004. doi: 10.1038/nrdp.2017.4. PMID: 28748977.
* Blakeley JO, Evans DG, Baser ME, et al. Neurofibromatosis type 2: a consensus update. Lancet Neurol. 2020 Jan;19(1):103-112. doi: 10.1016/S1474-4422(19)30382-7. PMID: 31759885.
* Blakeley JO, Evans DG, Galbraith J, et al. Schwannomatosis: consensus definitions, clinical and diagnostic criteria, and best practices. Neurology. 2020 Jul 14;95(2):29-41. doi: 10.1212/WNL.0000000000009710. PMID: 32434947.
* Stewart DR, Korf BR. Neurofibromatosis type 1: A review of the genetic and molecular biology. Semin Pediatr Neurol. 2019 Jun;30:100720. doi: 10.1016/j.spen.2019.03.003. PMID: 31103239.
* Boyd K, Korf BR. Neurofibromatosis Type 1 (NF1): Diagnosis and Management. Handb Clin Neurol. 2020;174:117-130. doi: 10.1016/B978-0-444-64032-1.00008-6. PMID: 32690374.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.